The companion diagnostics development services market, is anticipated to grow at a CAGR of over 10%, till 2035
Given the various challenges associated with co-development of companion diagnostics and drug / therapy, drug developers prefer to rely on third-party service providers that offer customized services and advanced technologies.
For additional details, please visit
https://www.rootsanalysis.com/....reports/view_documen
Like
Comment
Share
